BRYNJELSEN SEAN
Director, President & CEO · 1 filing · Latest: May 28, 2026
Eton Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ETON | BRYNJELSEN SEAN | Director, President & CEO | May 28, 2026 | Sale | $31.88 | 120,000 | $3.8M | 833,694 | |
ETON | BRYNJELSEN SEAN | — | May 28, 2026 | Proposed Sale | $32.40 | 120,000 | $3.9M | — | |
ETON | BRYNJELSEN SEAN | — | Jan 14, 2026 | Proposed Sale | $15.39 | 5,015 | $77.2K | — | |
ETON | BRYNJELSEN SEAN | — | Dec 12, 2025 | Proposed Sale | $16.88 | 8,035 | $135.6K | — | |
ETON | BRYNJELSEN SEAN | — | Jun 3, 2025 | Proposed Sale | $18.00 | 210,000 | $3.8M | — |